SKI Market

Indian Indices

Sensex

83,277.15 650.39
( 0.79%)

Global Indices

Nasdaq

49,514.94 41.95
(0.08%)

Dow Jones

6,856.39 2.63
(0.04%)

Hang Seng

56,974.47 32.50
(0.06%)

Nikkei 225

10,448.94 46.50
(0.45%)

Forex

USD-INR

90.59 -0.07
(-0.07%)

EUR-INR

107.56 -0.26
(-0.24%)

GBP-INR

123.48 -0.32
(-0.26%)

JPY-INR

0.59 0.00
(0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cholamandalam Investment & Finance Company Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

511243

INE121A01024

332.5875808

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CHOLAFIN

30.04

145545.21

EPS(TTM)

Face Value()

Div & Yield %

56.89

0.12

Back

Sun Pharma Advanced Research Company reports consolidated net loss of Rs 75.85 crore in the September 2025 quarter

Nov 11,2025

Net Loss of Sun Pharma Advanced Research Company reported to Rs 75.85 crore in the quarter ended September 2025 as against net loss of Rs 107.33 crore during the previous quarter ended September 2024. Sales declined 38.88% to Rs 7.86 crore in the quarter ended September 2025 as against Rs 12.86 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	7.86	12.86	-39
OPM %	-836.13	-800.23	-
PBDT	-73.23	-104.01	30
PBT	-75.79	-107.17	29
NP	-75.85	-107.33	29

83,277.15 650.39 ( 0.79%)

49,514.94 41.95 (0.08%)

6,856.39 2.63 (0.04%)

56,974.47 32.50 (0.06%)

10,448.94 46.50 (0.45%)

90.59 -0.07 (-0.07%)

107.56 -0.26 (-0.24%)

123.48 -0.32 (-0.26%)

0.59 0.00 (0.20%)